Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.04 Million USD | 1.97% |
| 2022 | 3.96 Million USD | 234.16% |
| 2021 | 1.18 Million USD | 243.15% |
| 2020 | 345.98 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | 254.6 Thousand USD | -40.0% |
| 2023 Q1 | 424.36 Thousand USD | -19.76% |
| 2023 FY | 4.04 Million USD | 1.97% |
| 2023 Q4 | 2.04 Million USD | 53.89% |
| 2023 Q3 | 1.32 Million USD | 420.82% |
| 2022 Q4 | 528.88 Thousand USD | -10.7% |
| 2022 Q3 | 592.23 Thousand USD | -68.42% |
| 2022 Q2 | 1.87 Million USD | 93.07% |
| 2022 FY | 3.96 Million USD | 234.16% |
| 2022 Q1 | 971.16 Thousand USD | 251.53% |
| 2021 Q1 | 137.31 Thousand USD | 100.41% |
| 2021 FY | 1.18 Million USD | 243.15% |
| 2021 Q4 | 276.26 Thousand USD | -35.02% |
| 2021 Q3 | 425.17 Thousand USD | 21.99% |
| 2021 Q2 | 348.52 Thousand USD | 153.81% |
| 2020 FY | 345.98 Thousand USD | 0.0% |
| 2020 Q4 | 68.51 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | 99.169% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | 92.002% |
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | 99.286% |
| Cosmos Health Inc. | 53.37 Million USD | 92.421% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -275.847% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | 96.522% |
| Cronos Group Inc. | 88.84 Million USD | 95.446% |
| Incannex Healthcare Limited | 12 Thousand USD | -33613.642% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | 96.846% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | 83.208% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | 83.208% |
| SCYNEXIS, Inc. | 140.14 Million USD | 97.113% |
| Safety Shot Inc | 202.67 Thousand USD | -1896.17% |
| Theratechnologies Inc. | 81.76 Million USD | 95.052% |
| Alpha Teknova, Inc. | 36.68 Million USD | 88.972% |
| Universe Pharmaceuticals INC | 32.3 Million USD | 87.478% |
| Pacira BioSciences, Inc. | 674.97 Million USD | 99.401% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | 68.232% |
| Dynavax Technologies Corporation | 232.28 Million USD | 98.258% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | 99.086% |
| Radius Health, Inc. | 2.88 Billion USD | 99.86% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -109.782% |
| Alvotech | 91.43 Million USD | 95.575% |
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | 99.129% |
| SIGA Technologies, Inc. | 139.91 Million USD | 97.109% |
| Shineco, Inc. | 9.8 Million USD | 58.726% |
| Silver Spike Investment Corp. | 11.72 Million USD | 65.487% |
| Journey Medical Corporation | 79.18 Million USD | 94.891% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | 30.516% |
| Embecta Corp. | 1.12 Billion USD | 99.639% |
| Harrow Health, Inc. | 130.19 Million USD | 96.893% |
| Procaps Group, S.A. | 409.92 Million USD | 99.013% |
| Biofrontera Inc. | 34.07 Million USD | 88.126% |
| DURECT Corporation | 8.54 Million USD | 52.672% |
| PainReform Ltd. | - USD | -Infinity% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | 99.334% |
| OptiNose, Inc. | 70.98 Million USD | 94.301% |
| RedHill Biopharma Ltd. | 6.51 Million USD | 37.885% |
| Organogenesis Holdings Inc. | 433.14 Million USD | 99.066% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | 89.771% |
| ProPhase Labs, Inc. | 44.38 Million USD | 90.885% |
| Phibro Animal Health Corporation | 1.01 Billion USD | 99.602% |
| Procaps Group S.A. | 409.92 Million USD | 99.013% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -210.725% |
| Viatris Inc. | 15.42 Billion USD | 99.974% |
| Rockwell Medical, Inc. | 83.61 Million USD | 95.161% |
| Aytu BioPharma, Inc. | 81 Million USD | 95.006% |
| Tilray Brands, Inc. | 788.94 Million USD | 99.487% |
| PetIQ, Inc. | 1.1 Billion USD | 99.633% |
| Talphera, Inc. | 651 Thousand USD | -521.45% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | 99.786% |
| Alimera Sciences, Inc. | 80.75 Million USD | 94.99% |
| Assertio Holdings, Inc. | 152.06 Million USD | 97.34% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | 85.532% |
| Alvotech | 91.43 Million USD | 95.575% |
| Lantheus Holdings, Inc. | 1.29 Billion USD | 99.688% |
| Kamada Ltd. | 144.75 Million USD | 97.205% |
| Currenc Group, Inc. | 53.25 Million USD | 92.403% |
| Indivior PLC | 1.09 Billion USD | 99.63% |
| Evoke Pharma, Inc. | 5.18 Million USD | 21.908% |
| Flora Growth Corp. | 76.07 Million USD | 94.682% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -275.847% |
| Evolus, Inc. | 202.08 Million USD | 97.998% |
| HUTCHMED (China) Limited | 837.99 Million USD | 99.517% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | 99.372% |
| Akanda Corp. | 2.16 Million USD | -87.294% |